Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Promoting excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Krzysztof Narkiewicz
The joint session of the European Society of Hypertension and European Society of Cardiology focused on a controversial issue of blood pressure goals of treatment. The validity of the goal of <130/80 mmHg previously recommended for high cardiovascular risk patients was questioned by all speakers due to the lack of evidence of clinical benefits. Giuseppe Mancia pointed out that analyses of recent trials raise the possibility that low achieved blood pressure values are associated with increased rather than decreased risk of coronary outcomes. Antonio Coca stressed that the previous recommendation to aim at a lower goal SBP (<130mmHg) in post-stroke patients is not supported by trial evidence, as in no randomized trial has SBP been brought down to below 130mmHg with proven benefits. Similar conclusions might be drawn from the studies in patients with type 2 diabetes which were reviewed by Peter Nilsson. He reminded that in the ACCORD BP study, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, did not reduce the rate of a composite outcome of cardiovascular events in patients with type 2 diabetes. Faiez Zannad stressed that BP management in heart failure patients, because of lack of specific clinical trials, is based solely on common sense. The main message from the session is that it may be prudent to recommend lowering SBP/DBP to values within the range 130–139/80–85mmHg, and possibly close to lower values in this range, in all hypertensive patients with preserved LV systolic function. Direct evidence in support of lowering systolic BP below 130 mmHg in high risk patients, including those with history of stroke, is urgently needed.
Blood pressure targets in cardiovascular risk patients - evidence or common sense